EUVIMEDEUVIMED entdecken
Open Access

Why do healthy volunteers participate in clinical trials?

Thijs van Iersel iD, Jelle Klein iD, Timothy C Hardman iD, Yves Donazzolo iD, Dick de Vries, Ingrid Klingmann iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Thijs van Iersel und 5 weiteren Autor:innen. Beteiligte Einrichtung: ICON, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Motivation, Healthy Volunteers, Clinical Trials, Phase I as Topic, Clinical Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To better understand the motivations and needs of healthy volunteers in clinical trials.

Methods

The European Federation for Exploratory Medicines Development (EUFEMED) devised a Survey of 58 questions on motivations of volunteers to participate, as well as on needs at the level of convenience, risk/benefit, social interaction, partnership and altruism. The Survey was shared with European Clinical Research Units (CRUs) who agreed to conduct the Survey in volunteers taking part in their phase 1 trials.

Results

The Survey generated responses from 4349 healthy volunteers. In 54% (95% CI: 52,55) of cases contributing to new treatments was the primary motivation to participate, vs . monetary compensation in 41% (95% CI: 39,42) of responders. Volunteer requirements during overnight stays defined as important were well‐functioning showers (89%, 95% CI: 87,90), ability to spend some time outside (78%, 95% CI: 76,80), the meal quality (76%, 95% CI 73,78), access to high‐speed internet (73%, 95% CI: 71,75), a place to read/work alone (69%, 95% CI: 66,71) and a good night rest (69%, 95% CI: 67,71). The opportunity to socialize with staff was important for 85% (95% CI: 83,87), a unit with a cozy interior for 70% (95% CI 67,72) and socializing with other participants for 63% (95% CI 61,66) of responders.

Conclusion

Healthy volunteers in clinical trials have specific needs during their stay in the Clinical Research Unit. Volunteer recruitment, compliance and retainment, as well as an ethical and a subject‐centric approach to trial design and conduct can benefit from understanding these needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MotivationHealthy VolunteersClinical Trials, Phase I as TopicClinical Trials as TopicResearch SubjectsHumansAltruismFemaleAdultMaleSurveys and QuestionnairesPatient SelectionMiddle AgedYoung Adult

Stichwörter der Autor:innen

Surveyclinical research unitearly clinical developmenthealthy volunteer centricitymotivationsneeds

Autor:innen und Institutionen

  • ICON, Groningen, the Netherlands.
  • SGS, Clinical Pharmacology Unit, Antwerpen, Belgium.
  • Niche Science & Technology Ltd, London, UK.
  • Eurofins Optimed, Grenoble, France.
  • Miltenyi, Leiden, the Netherlands.
  • Pharmaplex - President, EUFEMED, Wezembeek-Oppem, Belgium.

ORCID-Profile: Thijs van Iersel, Jelle Klein, Timothy C Hardman, Yves Donazzolo, Ingrid Klingmann

Zitieren

APA

van Iersel, T., Klein, J., Hardman, T. C., Donazzolo, Y., de Vries, D., & Klingmann, I. (2026). Why do healthy volunteers participate in clinical trials?. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70499

Vancouver

van Iersel T, Klein J, Hardman TC, Donazzolo Y, de Vries D, Klingmann I. Why do healthy volunteers participate in clinical trials?. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70499

BibTeX
@article{vanIersel2026,
  author = {van Iersel, Thijs and Klein, Jelle and Hardman, Timothy C and Donazzolo, Yves and de Vries, Dick and Klingmann, Ingrid},
  title = {Why do healthy volunteers participate in clinical trials?},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70499}
}
Kostenlos starten →